Patient Identification Quiz

Similar documents
Quiz 1: Terminology and Anatomy

SEER Summary Stage Still Here!

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

Requirements for Abstracted Text

Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.

Changes to SEER Data Set for Scope of Regional Lymph Node Surgery

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Prostate Overview Quiz

Interactive Discussion of Part I CS Coding Instructions: Working the Cases

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Quiz. b. 4 High grade c. 9 Unknown

2007 New Data Items. Slide 1. In this presentation we will discuss five new data items that were introduced with the 2007 MPH Coding Rules.

NAACR Treatment Webinar Quiz 1

Prostate Case Scenario 1

COLORECTAL CANCER CASES

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

The Alvin & Lois Lapidus Cancer Institute BREAST CANCER

Boot Camp Case Scenarios

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

Informational Abstracts: A Guide to Quality Abstracting

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Cancer Endorsement Maintenance 2011-Maintenance Measures

Melanoma Case Scenario 1

Melanoma Case Scenario 1

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

CS Evaluation Fields. Outline of Presentation. Purpose of Evaluation Field. CSv2 Title of Presentation Jan 2011 Lecture Version: 1.

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Recruiting Active; not recruiting Completed Suspended Terminated. The biological sex of the patient. Female Unknown

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Breast Cancer Diagnosis, Treatment and Follow-up

3. This data item records the grade of a solid primary tumor that had been resected following neoadjuvant therapy. a. Grade Post Therapy

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

A patient with recurrent bladder cancer presents with the following history:

TO SERVE YOU MORE EFFICIENTLY, PLEASE COMPLETE THIS FORM AND RETURN IT TO THE FRONT DESK BEFORE YOU ARE CALLED TO AN EXAM ROOM. THANK YOU.

Faster Cancer Treatment Indicators: Use cases

Coding Pitfalls 9/1/2011. Coding Pitfalls Questions. Fabulous Prizes!!! September 1, NAACCR Webinar Series 1

Multiple Primary Quiz

Collecting Cancer Data: Testis 2/3/11. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda. Fabulous Prizes

Guidelines for Assigning Summary Stage 2000

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Cancer Cases Treated and Results

Exercise. Discharge Summary

CASEFINDING. Debra W. Christie, MBA, RHIA, CTR, CCRP Director, Cancer Research & Data Center University of Mississippi Medical Center

Interactive Staging Bee

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

NATIONAL QUALITY FORUM

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after

Northumbria Healthcare NHS Foundation Trust. Breast Sentinel Lymph Node Biopsy. Issued by the Breast Team

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

I.2 CNExT This section was software specific and deleted in 2008.

Financial Disclosure. Learning Objectives. Review and Impact of the NCDB PUF. Moderator: Sandra Wong, MD, MS, FACS, FASCO

INTRODUCTION TO CANCER STAGING

GREATER BALTIMORE MEDICAL CENTER SANDRA & MALCOLM BERMAN CANCER INSTITUTE

2015 Public Outcomes Report Cancer Program Practice Profile Reports 2013 Breast and Colon Cancer

Attachment #2 Overview of Follow-up

Evaluation of Abstracting: Cancers Diagnosed in MCSS Quality Control Report 2005:2. Elaine N. Collins, M.A., R.H.I.A., C.T.R

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Case Scenario 1: Breast

When to worry, when to test?

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

11/21/13 CEA: 1.7 WNL

Patient Interview Form

CANCER PROGRAM Annual Report. Cancer Registry Database 2008 CANCER CASES AND BREAST CANCER SITE OUTCOMES ANALYSIS

Breast Cancer. Saima Saeed MD

Attachment #2 Overview of Follow-up

Chapter 2 Neoplasms C00-D49 November 11, Chapter 2: Neoplasms Category: C00-D49 Official Coding Guidelines: Section 1.C.2, p.

Intake and History Form

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

Chapter 2. Understanding My Diagnosis

PCSANM 2015 Seminar. Basic Knowledge: Test for Prostate Cancer. Jerry Cross. 15 item quiz, no grades given

Bringing the Fight to Cancer Annual Report

Adam J. Hansen, MD UHC Thoracic Surgery

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

Pregnancy in the middle of adjuvant treatment of Her2 positive breast cancer

2011 Physician Quality Reporting System Measures for Consideration by Oncology Providers: Cancer Care Measures

1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) =

Measure Name: Prostate Cancer: Cancer Surveillance Owner: NQF (#625) Steward: Active Health Management

2009 Cancer Committee

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

Neoplasms of the Prostate and Bladder

BREAST CANCER IN IDAHO

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

Collaborative Staging

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Cancer , The Patient Education Institute, Inc. ocf80101 Last reviewed: 06/08/2016 1

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.

Transcription:

Patient Identification Quiz 1. A patient presents to your facility for the first time on 1/1/2009. At that time he has a history of lymphoma (9590/3), melanoma (8720/3) and meningioma (9530/0). These three primaries were all diagnosed and treated at another hospital. The patient is diagnosed and treated for a primary adenocarcinoma (8140/3) of the prostate at your facility. What sequence number should be assigned to the prostate primary? a. 00 b. 03 c. 04 d. 60 2. You have been asked by your cancer committee to begin collecting Prostatic Intraepithelial Neoplasia III (PIN III) cases (8148/2). These cases are not required by your state registry or by the NCDB. The first PIN III patient you abstract has a history of lung cancer. What sequence number should be assigned to the PIN III? a. 01 b. 02 c. 60 d. 61 3. In 2008 you completed an abstract for a patient with colon cancer that had metastasized to the lung. The case is complete and has been submitted to the state cancer registry. You recently discovered that what was originally thought to be metastasis was a lung primary. What should you do? a. Abstract the lung primary with sequence 02. b. Change the sequence for the colon primary from 00 to 01. c. Update the text in the colon primary. d. Submit a change form to the central registry reflecting the new sequencing. e. All of the above.

4. Assign Race and Spanish/Hispanic Origin codes to the following scenarios. a. 62 year old Brazilian female b. 43 year old Asian male born in Japan c. 74 year old Mexican male d. 23 year old Japanese/Hawaiian male e. 89 year old black Dominican male f. 62 year old Spanish female g. 53 year old male of Cherokee descent h. The patient stated his mother was white and his father was second generation Korean, hi s grandfather was Hawaiian and his grandmother was Native American. Race 1 Race 2 Race 3 Race 4 Spanish/Hispanic Origin 5. A patient was admitted with the following diagnoses. ADMIT: 285.8 PRINC: 285.9 Anemia Anemia SEC: E933.1 Adverse effects antineoplastic 199.1 Malignant Neoplasm, NOS 197.0 Secondary Malign neoplasm lung 198.3 Sec Mal neo brain/spine 401.9 Hypertension 272.4 Hyperlipidemia nec/nos 427.31 Atrial Fibrillation 272.0 Pure Hypercholesterolemia Which codes should be included as comorbidities 1 10. Comorbid codes: 1. 2. 3. 4. 5. 6. 7. 8. 9. 10.

Cancer Identification Quiz For questions 1 6 assign a class or case or NA for not applicable. Class of case codes are provided on the following page. 1. A patient was diagnosed at another facility with breast cancer. She came to your facility for a wire localization which was done in the radiology department. She then went to a free standing surgical center (not owned by the reporting facility) for a lumpectomy. 2. A breast cancer patient was diagnosed elsewhere and came to your facility for a sentinel lymph node dissection. No malignancy was identified in the lymph nodes. No further work up or treatment was done at the reporting facility. 3. A breast cancer patient was diagnosed elsewhere and presents to your facility for a consult. Radiation, chemotherapy and hormone treatment are recommended. The patient refused all treatment. 4. During an organ harvest being performed at your facility a patient was found to have a primary lung cancer. Cancer was not suspected prior to the patient expiring. 5. A lung cancer patient was diagnosed at another facility and presents to your facility for a staging work up. The patient then went on to get chemotherapy at a staff physician s office. 6. A lung cancer patient was diagnosed at another facility. At that facility a biopsy was done of the primary tumor that confirmed malignancy. A CT was done that showed a lesion on the chest wall that was suspicious for metastasis. The patient presented to your facility for a biopsy of the lesion. The biopsy was performed and confirmed metastasis from the lung primary. The patient then went to one of your staff physician offices for treatment.

Class 0 Diagnosed at facility and first course of treatment elsewhere Class 1 Diagnosed at facility and all or part of first course of treatment performed at reporting facility Class 2 Diagnoses elsewhere and all or part of first course of treatment at reporting facility Class 3 Diagnosed and all of first course of treatment performed elsewhere Class 4 Diagnosed and/or first course of treatment before reference date Class 5 Diagnosed at autopsy Class 6 Diagnosed and first course of treatment at staff physician s office Class 7 Pathology report only Class 8 Death certificate only Class 9 Unknown NA Not Applicable Case is not reportable 7. A patient with pneumonia is referred to your radiology department for a chest CT on 1/1/2009. The CT shows a suspicious lesion in the upper lobe of the left lung. The patient is admitted on 1/15/2009 due to the pneumonia. On 1/17/09 (during the same stay) a bronchoscopy is performed and the lesion in the left upper lobe was biopsied. Pathology confirmed malignancy. a. What is the Date of First Contact? b. What is the Date of Diagnosis? 8. A pathology report showed endometrioid adenocarcinoma of the endometrium grade 2/3. What code should be used for Grade? a. 1 b. 2 c. 3 d. 4 9. A colonoscopy with biopsy was performed and the pathology returned as high grade adenocarcinoma grade 2/2. What code should be used for Grade? a. 1 b. 2 c. 3 d. 4 10. A prostate biopsy returned as adenocarcinoma Gleason s 4+3=7. What code should be used for Grade? a. 1 b. 2 c. 3 d. 4

Stage and Treatment Quiz 1. Classify the following procedures as either Dx (diagnostic/staging) or Tx (surgical treatment) a. Colonoscopy with biopsy of a large ulcerated mass. b. Colonoscopy with polypectomy. c. Excisional biopsy of a 4cm breast mass. d. Core needle biopsy of a 4cm breast mass. e. Patient with widespread lymphadenopathy has an excisional biopsy of single inguinal lymph. Pathology is positive for lymphoma. 2. Select the locations where AJCC physician clinical staging may be documented (circle all that apply). a. Nurses Notes b. Pre-surgical physical exam c. Treatment plan d. In clinical or consultation notes e. Laboratory results f. Hospital medical record g. Physician office records h. Deficiency notifications 3. A patient with prostate cancer was given the options of either a radical prostatectomy or radioactive seed implants. The patient chose to have radioactive seed implants. What is Reason No Surgery? a. 0 Surgery of the primary site was performed. b. 1 Surgery of the primary site was not performed because it was not part of the planned first course treatment. c. 7 Surgery of the primary site was not performed; it was recommended by the patient s physician, but this treatment was refused by the patient, the patient s family member, or the patient s guardian. d. 9 It is unknown whether surgery of the primary site was recommended or performed. Diagnosed at autopsy or death certificate only. 4. During a radical nephrectomy for kidney cancer a patient had a bradycardiac episode. The procedure cancelled before the kidney was removed. It was later decided that the patient would not have the procedure due to poor performance status. What is Reason for no surgery? a. 0 Surgery of the primary site was performed. b. 1 Surgery of the primary site was not performed because it was not part of the planned first course treatment. c. 2 Surgery of the primary site was not recommended/performed because it was contraindicated due to patient risk factors (comorbid conditions, advanced age, etc.) d. 9 It is unknown whether surgery of the primary site was recommended or performed. Diagnosed at autopsy or death certificate only.

5. A patient is seen at your facility on 2/3/09 for chest x ray and CT of the chest and abdomen. Results indicate extensive carcinomatosis due to ovarian primary. Surgeon performs paracentesis for comfort measure only. The paracentesis should be coded as: a. Surgery of Primary Site b. Palliative Treatment c. Surgery of Other Regional Distant Sites d. Other Treatment